ClinicalCodes.org

An online clinical codes repository to improve validity and reproducibility of medical database research

Research article:

Examining variations in prescribing safety in UK general practice: a cross-sectional study using the Clinical Practice Research Datalink

Reference:

S Jill Stocks, Evangelos Kontopantelis, Artur Akbarov, Sarah Rodger, Anthony J Avery, Darren M Ashcroft(2015) Examining variations in prescribing safety in UK general practice: a cross-sectional study using the Clinical Practice Research Datalink. BMJ, doi: 10.1136/bmj.h5501

Link to fulltext article
Abstract
Study question What is the prevalence of different types of potentially hazardous prescribing in general practice in the United Kingdom, and what is the variation between practices? Methods A cross sectional study included all adult patients potentially at risk of a prescribing or monitoring error defined by a combination of diagnoses and prescriptions in 526 general practices contributing to the Clinical Practice Research Datalink (CPRD) up to 1 April 2013. Primary outcomes were the prevalence of potentially hazardous prescriptions of anticoagulants, anti-platelets, NSAIDs, β blockers, glitazones, metformin, digoxin, antipsychotics, combined hormonal contraceptives, and oestrogens and monitoring by blood test less frequently than recommended for patients with repeated prescriptions of angiotensin converting enzyme inhibitors and loop diuretics, amiodarone, methotrexate, lithium, or warfarin. Study answer and limitations 49 927 of 949 552 patients at risk triggered at least one prescribing indicator (5.26%, 95% confidence interval 5.21% to 5.30%) and 21 501 of 182 721 (11.8%, 11.6% to 11.9%) triggered at least one monitoring indicator. The prevalence of different types of potentially hazardous prescribing ranged from almost zero to 10.2%, and for inadequate monitoring ranged from 10.4% to 41.9%. Older patients and those prescribed multiple repeat medications had significantly higher risks of triggering a prescribing indicator whereas younger patients with fewer repeat prescriptions had significantly higher risk of triggering a monitoring indicator. There was high variation between practices for some indicators.Though prescribing safety indicators describe prescribing patterns that can increase the risk of harm to the patient and should generally be avoided, there will always be exceptions where the indicator is clinically justified. Furthermore there is the possibility that some information is not captured by CPRD for some practices—for example, INR results in patients receiving warfarin. What this study adds The high prevalence for certain indicators emphasises existing prescribing risks and the need for their appropriate consideration within primary care, particularly for older patients and those taking multiple medications. The high variation between practices indicates potential for improvement through targeted practice level intervention.
Author for correspondence
Jill Stocks
Email for correspondence
jill.stocks@manchester.ac.uk

Code list: res25: P1asthma

39 codes in list

Code Coding system Description Entity type List name
14B4.00 Read H/O: asthma diagnostic res25: P1asthma
173d.00 Read Work aggravated asthma diagnostic res25: P1asthma
1O2..00 Read Asthma confirmed diagnostic res25: P1asthma
2126200 Read Asthma resolved diagnostic res25: P1asthma
212G.00 Read Asthma resolved diagnostic res25: P1asthma
8H2P.00 Read Emergency admission, asthma diagnostic res25: P1asthma
H312000 Read Chronic asthmatic bronchitis diagnostic res25: P1asthma
H312011 Read Chronic wheezy bronchitis diagnostic res25: P1asthma
H33..00 Read Asthma diagnostic res25: P1asthma
H330.00 Read Extrinsic (atopic) asthma diagnostic res25: P1asthma
H330000 Read Extrinsic asthma without status asthmaticus diagnostic res25: P1asthma
H330011 Read Hay fever with asthma diagnostic res25: P1asthma
H330100 Read Extrinsic asthma with status asthmaticus diagnostic res25: P1asthma
H330.11 Read Allergic asthma diagnostic res25: P1asthma
H330111 Read Extrinsic asthma with asthma attack diagnostic res25: P1asthma
H330.12 Read Childhood asthma diagnostic res25: P1asthma
H330.13 Read Hay fever with asthma diagnostic res25: P1asthma
H330.14 Read Pollen asthma diagnostic res25: P1asthma
H330z00 Read Extrinsic asthma NOS diagnostic res25: P1asthma
H331.00 Read Intrinsic asthma diagnostic res25: P1asthma
H331000 Read Intrinsic asthma without status asthmaticus diagnostic res25: P1asthma
H33..11 Read Bronchial asthma diagnostic res25: P1asthma
H331100 Read Intrinsic asthma with status asthmaticus diagnostic res25: P1asthma
H331.11 Read Late onset asthma diagnostic res25: P1asthma
H331111 Read Intrinsic asthma with asthma attack diagnostic res25: P1asthma
H331z00 Read Intrinsic asthma NOS diagnostic res25: P1asthma
H332.00 Read Mixed asthma diagnostic res25: P1asthma
H333.00 Read Acute exacerbation of asthma diagnostic res25: P1asthma
H334.00 Read Brittle asthma diagnostic res25: P1asthma
H33z.00 Read Asthma unspecified diagnostic res25: P1asthma
H33z000 Read Status asthmaticus NOS diagnostic res25: P1asthma
H33z011 Read Severe asthma attack diagnostic res25: P1asthma
H33z100 Read Asthma attack diagnostic res25: P1asthma
H33z111 Read Asthma attack NOS diagnostic res25: P1asthma
H33z200 Read Late-onset asthma diagnostic res25: P1asthma
H33zz00 Read Asthma NOS diagnostic res25: P1asthma
H33zz11 Read Exercise induced asthma diagnostic res25: P1asthma
H33zz12 Read Allergic asthma NEC diagnostic res25: P1asthma
H47y000 Read Detergent asthma diagnostic res25: P1asthma

0 comments have been posted.

Please log in to leave a comment.